MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 18 filers reported holding MILESTONE PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $108,000 | -30.3% | 18,704 | -18.9% | 0.00% | – |
| Q4 2020 | $155,000 | -8.3% | 23,065 | 0.0% | 0.00% | – |
| Q3 2020 | $169,000 | +94.3% | 23,065 | 0.0% | 0.00% | – |
| Q2 2020 | $87,000 | +107.1% | 23,065 | 0.0% | 0.00% | – |
| Q1 2020 | $42,000 | -92.8% | 23,065 | -36.4% | 0.00% | -100.0% |
| Q4 2019 | $581,000 | -7.3% | 36,265 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $627,000 | – | 36,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,425,737 | $22,293,000 | 3.44% |
| Lion Point Capital, LP | 1,557,233 | $11,186,000 | 2.46% |
| ACUTA CAPITAL PARTNERS, LLC | 597,026 | $5,487,000 | 2.36% |
| Ikarian Capital, LLC | 855,616 | $7,863,000 | 1.57% |
| GREAT POINT PARTNERS LLC | 674,656 | $6,200,000 | 1.49% |
| Bleichroeder LP | 512,500 | $4,710,000 | 0.98% |
| RTW INVESTMENTS, LP | 4,315,102 | $39,656,000 | 0.91% |
| Novo Holdings A/S | 2,000,000 | $18,380,000 | 0.88% |
| Paradigm Biocapital Advisors LP | 634,211 | $5,828,000 | 0.78% |
| Ikarian Capital, LLC | 338,000 | $3,107,000 | 0.62% |